BGB-A317-305 JapicCTI-194799

Active, not recruiting

Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma

Beigene Study ID info

BGB-A317-305 JapicCTI-194799

ClinicalTrials.gov ID info

EudraCT Number info

2018-000312-24

Clinical Drug Trials ID info

CTR20181841

Study Overview

Sex: All

Age: 18 Years and older   (Adult, Older Adult)

No Study Documents

Study Overview

Sex: All

Age: 18 Years and older   (Adult, Older Adult)

No Study Documents